Arcus Biosciences Cash from Operations (TTM) Analysis

Arcus Biosciences Inc (RCUS)

15.50 +0.27 (+1.77%) USD | NYSE | May 01, 16:00

15.50 0.00 (0.00%) After-Hours: 19:37

Cash from Operations (TTM) Chart

Historical Cash from Operations (TTM) Data

View and export this data back to 2017. Upgrade now.

Date	Value
December 31, 2023	-306.00M
September 30, 2023	-288.00M
June 30, 2023	-306.00M
March 31, 2023	-314.00M
December 31, 2022	438.00M
September 30, 2022	446.07M
June 30, 2022	473.31M
March 31, 2022	464.32M
December 31, 2021	-256.00M
September 30, 2021	-244.12M
June 30, 2021	25.90M
March 31, 2021	75.96M
December 31, 2020	111.00M

Date	Value
September 30, 2020	151.58M
June 30, 2020	-92.08M
March 31, 2020	-87.90M
December 31, 2019	-73.46M
September 30, 2019	-71.10M
June 30, 2019	-55.46M
March 31, 2019	-46.59M
December 31, 2018	-43.00M
September 30, 2018	-20.30M
June 30, 2018	-32.77M
March 31, 2018	-28.71M
December 31, 2017	-25.06M

Cash From Operations Definition

Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.

Read full definition.

Cash from Operations (TTM) Range, Past 5 Years

-314.00M

Minimum

Mar 2023

473.31M

Maximum

Jun 2022

4.843M

Average

-71.10M

Median

Sep 2019

Cash from Operations (TTM) Benchmarks